comparemela.com

First Trimester Screening Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MS Meds in Breastfeeding Mothers Safe for Infants

Breastfeeding by women with MS or NMSOD who are taking anti-CD20 IgG1 monoclonal antibodies appears to be safe for infants, new research suggests.

United statesSan franciscoAnnika andersonUniversity of californiaFirst trimester screening programJohns hopkins school of medicineResearch in multiple sclerosisWeill institute for neurosciencesEuropean committee for treatmentWeill instituteEuropean committeeMultiple sclerosisStages questionnairesMedscape medical newsAngie child jelinJohns hopkins school

Reassuring Data for Two Multiple Sclerosis Meds in Pregnancy

Two studies report few complications from continuing ocrelizumab and natalizumab into pregnancy, with high live birth rates, a decline in elective abortions, and few major congenital abnormalities in newborns.

Celia oreja guevaraSandra thielDepartment of neurologyUniversity hospital san carlosRuhr university bochumFirst trimester screening programSclerosis centerJohns hopkins school of medicineResearch in multiple sclerosisEuropean committee for treatmentJosef hospitalEuropean committeeMultiple sclerosisMultiple sclerosis centerGerman multiple sclerosisPregnancy registry

vimarsana © 2020. All Rights Reserved.